Nutex Health (NASDAQ:NUTX) Shares Down 5.5% – What’s Next?

Nutex Health Inc. (NASDAQ:NUTX)’s share price traded down 5.5% during trading on Tuesday . The company traded as low as $194.35 and last traded at $186.6230. 23,936 shares were traded during mid-day trading, a decline of 86% from the average session volume of 172,066 shares. The stock had previously closed at $197.51.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. Zacks Research upgraded shares of Nutex Health to a “hold” rating in a research note on Monday, June 29th. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 20th. B. Riley Financial initiated coverage on shares of Nutex Health in a report on Friday, June 26th. They set a “buy” rating and a $290.00 target price on the stock. Finally, Lake Street Capital reaffirmed a “buy” rating and set a $310.00 price target on shares of Nutex Health in a research report on Tuesday. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $268.33.

Nutex Health Stock Down 13.1%

The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The stock has a market capitalization of $1.18 billion, a price-to-earnings ratio of 6.64 and a beta of 0.24. The firm’s fifty day moving average is $158.62 and its 200-day moving average is $129.35.

Hedge Funds Weigh In On Nutex Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Islay Capital Management LLC bought a new position in Nutex Health in the 4th quarter worth approximately $34,000. BNP Paribas Financial Markets lifted its holdings in shares of Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares during the last quarter. Royal Bank of Canada lifted its position in shares of Nutex Health by 752.4% in the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after acquiring an additional 316 shares in the last quarter. Bank of America Corp DE grew its holdings in shares of Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. Finally, EverSource Wealth Advisors LLC acquired a new position in shares of Nutex Health in the 1st quarter valued at about $83,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.